Alfasigma

Alfasigma

Alfasigma, formerly Pamlab, is a company that develops personalized pharmaceuticals and medicine

Alfasigma is based in Los Angeles, California, United States.

The company works with drugs such as Deplin L-methylfolate Ca, VSL#3 The Living Shield, Metanx L-methylfolate Ca/P-5-P/Me-Cbl, CerefolinNAC L-methylfolate Ca/Me-Cbl/NAC, Carnitine bulk ingredients, Brand Direct Health, PrOxeedPluss, and NeevoDHA.

Alfasigma acquired ZELNORM in March of 2019. Zelnorm is a prescription pharmaceutical treatment option for irritable bowel syndrome with constipation. The drug works by targeting the 5-HT4 receptor at multiple neurons, and smooth muscle cells in the gastrointestinal tract to induce contraction and relaxation. It also aims to decrease pain signaling.

The company acquired DELPIN which is a drug designed to help meet the nutritional needs of people with depression and is usable with antidepressants. It is formulated with L-methylfolate and can be used after initial antidepressant therapy.

Timeline

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Add the Missing Peace

Web

Alfasigma USA, Inc.

Web

Alfasigma USA, Inc.

Web

Zelnorm - Alfsasigma USA, Inc.

Web

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

Pamlab (Alfasigma)

Los Angeles, California, United States

Personalized Pharmaceuticals

News

Title
Author
Date
Publisher
Description
Cision Portugal SA
February 6, 2021
www.prnewswire.com:443
/PRNewswire/ -- Alfasigma Spa hat eine Lizenzvereinbarung zum Vertrieb von LumeblueTM in der EU (plus Schweiz, Großbritannien, Länder des Europäischen...
Cision Portugal SA
February 6, 2021
www.prnewswire.com:443
/PRNewswire/ -- Alfasigma Spa ha concluido un acuerdo de licenciamiento con Cosmo Pharmaceuticals para distribuir LumeblueTM en la Unión Europea (además de...
Cision Portugal SA
February 5, 2021
www.prnewswire.com:443
/PRNewswire/ -- Alfasigma Spa ha finalizado un acuerdo de licencia para distribuir LumeblueTM en la UE (más Suiza, Reino Unido, países del Espacio Económico...
Alfasigma
January 29, 2021
www.prnewswire.com:443
/PRNewswire/ -- A Alfasigma lançou recentemente uma série de atividades digitais que ampliam sua presença na Internet e melhoram seus pontos de contato em todo...
Alfasigma
January 29, 2021
www.prnewswire.com:443
/PRNewswire/ -- Alfasigma hat kürzlich eine Reihe von digitalen Aktivitäten gestartet, die die Webpräsenz erweitern und die Touchpoints auf der ganzen Welt...
Alfasigma
January 28, 2021
www.prnewswire.com:443
/PRNewswire/ -- Alfasigma ha lanzado recientemente una serie de actividades digitales que amplían su presencia en la Web y mejoran sus puntos de contacto en...
Alfasigma
January 28, 2021
www.prnewswire.com:443
/PRNewswire/ -- Alfasigma ha lanzado recientemente una serie de actividades digitales que amplían su presencia web y mejoran sus puntos de contacto en todo el...
Alfasigma
January 28, 2021
www.prnewswire.com:443
/PRNewswire/ -- Alfasigma has recently launched a number of digital activities that expand its web presence and improves its touchpoints around the world....

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.